TP53 and serous adenocarcinoma: It is known that p53 IHC is only approximately 95% sensitive for TP53 mutation in tubo-ovarian high-grade serous carcinoma [35]; in these tumours the p53 protein is present at levels comparable to what is seen in tumours without a TP53 mutation, resulting in wild type staining pattern but an inactive protein.